Acne Therapeutics Market

Acne Therapeutics Market, By Treatment (Therapeutics, Retinoid, Antibiotics, Hormonal Agents, Combination Medications, Anti-inflammatory, and Other Agents) and By Route of Administration (Oral, Topical, and Others), And By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Acne is the common skin condition where the pores of the skin clog, and pore blockages leads to blackheads, whiteheads, and/or pimples. Acne affect around 9.4% of the global population, making it one of the most prevalent disease worldwide. Hence, there is an increasing demand for safe and effective acne therapeutics. Acne therapeutics include over-the-counter creams, gels, and cleanser, as well as prescription antibiotics.

Market Dynamics:

Increasing prevalence of acne, increasing demand for safe/effective acne therapeutics, increasing research and development (R&D), and growing awareness among people about acne products and available treatment options are some major factors expected to augment the growth of the global acne therapeutics market during the forecast period.

For instance, in July 2022, STRATA Skin Sciences, Inc. announced the launch of TheraClearX, a non-invasive, in-office acne treatment targeting the root causes of mild to moderate acne, including comedonal, pustular, and inflammatory acne vulgaris.

Key features of the study:

• This report provides in-depth analysis of the global acne therapeutics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global acne therapeutics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Allergan, Ranbaxy, Bayer Ag, Johnson & Johnson, Nestlé SA (Galderma), Glaxosmithkline Plc, Teva Pharmaceuticals, Cipher Pharmaceuticals, F. Hoffmann-la Roche Ltd., and Valeant Pharmaceuticals International Inc., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global acne therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acne therapeutics market.

Detailed Segmentation:

• Global Acne Therapeutics Market, By Treatment:
• Therapeutics
• Retinoid
• Antibiotics
• Hormonal Agents, Combination Medications, Anti-inflammatory
• Other Agents
• Global Acne Therapeutics Market, By Route of Administration:
• Oral
• Topical
• Others
• Global Acne Therapeutics Market, By Geography:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa
• Company Profiles:
• Allergan
• Ranbaxy
• Bayer Ag
• Johnson & Johnson
• Nestlé SA (Galderma)
• Glaxosmithkline Plc
• Teva Pharmaceuticals
• Cipher Pharmaceuticals
• F.Hoffmann-la Roche Ltd.
• Valeant Pharmaceuticals International Inc.